Latest Articles

Publication Date
New treatment option for endometriosis approved in Scotland - PharmaTimes

New treatment option for endometriosis approved in Scotland PharmaTimes

Published: Oct. 13, 2025, 11:09 a.m.
Grindr adds new uncensored content hub to its app - Mashable

Grindr adds new uncensored content hub to its app Mashable

Published: Oct. 12, 2025, 9 a.m.
US appeals court: No National Guard deployment in Chicago - lnginnorthernbc.ca

US appeals court: No National Guard deployment in Chicago lnginnorthernbc.ca

Published: Oct. 12, 2025, 7:56 a.m.
The best (and most discreet) sexting apps for NSFW chats - Mashable

The best (and most discreet) sexting apps for NSFW chats Mashable

Published: Oct. 11, 2025, 9:48 a.m.
Biomarkers and Immunotherapy in Endometrial Cancer: Mechanisms and Clinical Applications - Frontiers

Biomarkers and Immunotherapy in Endometrial Cancer: Mechanisms and Clinical Applications Frontiers

Published: Oct. 6, 2025, 5:06 p.m.
Apple Watch Series 11 deal: Get $10 off at Amazon - Mashable

Apple Watch Series 11 deal: Get $10 off at Amazon Mashable

Published: Oct. 4, 2025, 11:36 p.m.
Ten-Year Single-Centre Study Compares Surgical Approaches for Advanced Endometrial Cancer - Docwire News

Ten-Year Single-Centre Study Compares Surgical Approaches for Advanced Endometrial Cancer Docwire News

Published: Oct. 2, 2025, 10:50 p.m.
MLAs urge cross-Border approach to endometriosis care - The Impartial Reporter

MLAs urge cross-Border approach to endometriosis care The Impartial Reporter

Published: Oct. 2, 2025, 4:07 a.m.
5 things period apps don’t tell you about your cycle - MSN

5 things period apps don’t tell you about your cycle MSN

Published: Oct. 1, 2025, 8:47 a.m.
Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis - beQuoted

Gesynta Pharma receives UK approval for a Phase 2 trial of vipoglanstat in endometriosis beQuoted

Published: Sept. 30, 2025, 8 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!